Neurology

“Neuroinflammation in Alzheimer’s disease might be partially caused by viral, bacterial and fungal pathogens entering the brain through the nose and the olfactory system”

The National Technical University of Athens (NTUA) is playing an influential role in the development of the Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders (MES-CoBraD) for faster and more accurate diagnosis of complex brain diseases.

Neuralink Corp is developing a brain implant aimed at assisting paralyzed individuals in walking again and treating other neurological disorders

According to one study, a 1% loss in deep sleep each year for persons over 60 years old translates into a 27% higher chance of dementia.

Alamy Photo

Germany-based biotechnology company BioNTech and Türkiye's Koç University have signed a collaboration agreement that encompasses a series of clinical research, mainly cancer treatments.

A Turkish neurology professor studying in the United States has received a $41 million government grant for her groundbreaking research on Alzheimer's disease and how it affects people of different ethnic groups.

According to a study, those with low bone density may be more likely than those with high bone density to get dementia.The findings of the study published in the online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that low bone density causes dementia....

Encouraging results have emerged from the multi-year research of a team of scientists at the Demokritos National Center of Scientific Research giving hope of future tools for the better treatment of conditions that affect the central nervous system, such as Alzheimer's disease and malignant brain tumors.

The Slovenian neuroscience company BrainTrip has presented a new dementia screening test that will help doctors detect the disease early. An early diagnosis can increase treatment options, experts say.

"We have cases of young patients who have had strokes, and the only reason we find this after extensive research is the post-COVID-19 experience." This is what the head of the Clinic of Nervous Diseases at the University Hospital "St. Anna " Assoc. Prof. Rosen Kalpachki said.